用于预测急性心肌梗塞患者心力衰竭的血生物标志物
Rong Guihong1, Wang Xiao1, Qin Xinling1
1Affiliated Hospital of Guilin Medical University, Department of Clinical Laboratory, Guilin, China.
Journal of medical biochemistry
|February 24, 2025
概括
像NT-proBNP,NLR和GDF-15这样的生物标志物可以在急性心肌梗塞 (AMI) 后预测心力衰竭 (HF). 早期识别这些高频生物标志物有助于制定及时的治疗策略,以获得更好的患者结果.
科学领域:
- 心脏病学 心脏病学
- 生物标志物发现发现
- 临床预后 临床预后
背景情况:
- 急性心肌梗塞 (AMI) 后的心力衰竭 (HF) 导致高死亡率.
- 及时恢复血管是管理后AMIHF的关键.
- 对于后AMI HF的NT-proBNP,cTNT,PLR,NLR和GDF-15等生物标志物的预测价值需要进一步调查.
研究的目的:
- 确定用于预测AMI后HF发展的有力生物标志物.
- 设计早期拦截和治疗策略,用于后AMI高频率.
- 评估NT-proBNP,cTNT,PLR,NLR和GDF-15的预测准确性在AMI后的高血压炎患者中.
主要方法:
- 纳入了170名AMI患者 (44人患有AMI后高血压,126人没有).
- 血清生物标志物 (NT-proBNP,cTNT,PLR,NLR,GDF-15) 使用ELISA进行测量.
- 使用T测试来评估生物标志物的预测价值,以评估后AMI高频率的生物标志物.
主要成果:
- 在高频组中,NT-proBNP,GDF-15和NLR水平显著更高.
- 两组之间PLR水平没有显著差异.
- 在NT-proBNP中,预测值最高 (AUC=0.82),其次是GDF-15 (AUC=0.661) 和NLR (AUC=0.632).
结论:
- NT-proBNP,NLR和GDF-15是预测HF后AMI的有价值的生物标志物.
- 这些生物标志物可以帮助早期风险分层和管理后AMI HF.
- 进一步的研究可能会根据这些预测标记来完善治疗策略.
更多相关视频
04:41Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
8.1K
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
3.4K
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
81
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
81
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
41
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
41
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K